Showing 31-38 of 38 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Development of a trans-ancestral genetic risk score for type 1 diabetes | Centre hospitalier universitaire Sainte-Justine | Despoina Manousaki | Cures | 01-August-2022 to 31-July-2025 | $577.621,93 |
| Targeting Novel GPCRs to Promote Beta Cell Survival | Sunnybrook Research Institute | Robert Screaton | Cures | 01-February-2022 to 28-February-2026 | $110.000,00 |
| A pH responsive hydrogel microneedle patch for continuous measurement of ketone bodies and glucose | University of Waterloo | Mahla Poudineh | Improving Lives | 01-May-2022 to 30-September-2026 | $1.349.517,38 |
| A Novel, Dual-Hormone, Fully Automated Artificial Pancreas for Type 1 Diabetes | McGill University | Ahmad Haidar | Improving Lives | 01-October-2021 to 01-January-2026 | $899.952,00 |
| Vascular regenerative biomaterial (MAA) for islet transplantation | The Governing Council of the University of Toronto | Michael Sefton | Cures | 01-August-2021 to 30-November-2025 | $506.807,41 |
| Clinical Phase II/III Trial to treat type 1 diabetes (UST1D2) | The University of British Columbia | Jan Dutz | Cures | 01-November-2020 to 31-December-2027 | $538.854,00 |
| Implementing a virtual care platform to improve mental health for type 1 diabetes in rural and remote regions of Interior British Columbia | The University of British Columbia | Tricia Tang | Improving Lives | 01-April-2020 to 30-January-2026 | $393.786,60 |
| Harmonizing biomarkers in clinical trials of ustekinumab | The University of British Columbia | Megan Levings | Cures | 01-July-2018 to 30-June-2027 | $660.059,94 |